Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
GenEdit
AddedFeb 15, 2024
UpdatedJun 18, 2026
GenEdit

GenEdit

Series A

GenEdit Inc., a biotech firm in California, innovates CRISPR-based therapeutic delivery systems.

HQ
South San Francisco, CA, US
Founded
2016
Overview
Compare
Fundraising
Employees
Website

GenEdit Inc., founded in California, is a biotechnology company dedicated to developing innovative delivery systems for CRISPR-based therapeutics. Their core mission is to revolutionize genetic medicine by creating precise and efficient delivery mechanisms for gene editing technologies. GenEdit's vision is to unlock the full potential of genetic therapies to treat a wide range of diseases. The company focuses on providing comprehensive solutions that enhance the efficacy and safety of CRISPR-based treatments, targeting both rare and common genetic disorders.

Notable figures associated with GenEdit include experts in biotechnology and genetic research, though specific names are not provided. The company has attracted significant interest from investors in the biotech sector, reflecting confidence in its cutting-edge approach. Key achievements include the development of proprietary delivery platforms that have shown promise in preclinical studies. GenEdit's impact lies in its potential to transform the landscape of genetic medicine, offering hope for more effective treatments and cures for genetic diseases.

GenEdit - Similar Companies

Editas Medicine logo

Editas Medicine

Synthego logo

Synthego

synthego.com

Mammoth Biosciences logo

Mammoth Biosciences

Intellia Therapeutics logo

Intellia Therapeutics

intelliatx.com

Amber Bio logo

Amber Bio

amber.bio

Acrigen Biosciences logo

Acrigen Biosciences

acrigen.com

eGenesis logo

eGenesis

egenesisbio.com

Metagenomi logo

Metagenomi

metagenomi.co

Scribe Therapeutics logo

Scribe Therapeutics

scribetx.com

Genetica logo

Genetica

genetica.asia

GeneTether logo

GeneTether

genetether.com

CellFE logo

CellFE

Caribou Biosciences logo

Caribou Biosciences

cariboubio.com

Nvelop Therapeutics logo

Nvelop Therapeutics

Emendo Biotherapeutics logo

Emendo Biotherapeutics

emendobio.com

GenEdit - Quick Facts

Who are GenEdit's competitors?

Companies similar to GenEdit include Editas Medicine, Synthego, Mammoth Biosciences and Intellia Therapeutics.

When was GenEdit founded?

GenEdit was founded in 2016.

Where is GenEdit's headquarters located?

GenEdit's headquarters is located in South San Francisco, CA, US.

When was GenEdit's last funding round?

GenEdit's most recent funding round was for $24M (USD) in January 2024.

How much has GenEdit raised to-date?

As of Jan 23, 2024, GenEdit has raised a total of $67.7M (USD).

How many employees does GenEdit have?

GenEdit has 47 employees as of Feb 4, 2024.

GenEdit - Classification

Ownership
  • Private
  • Venture Capital
Technology
  • Biotech
  • Crispr
Geographic Exposure
  • United States
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Therapeutic Delivery
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 4 more industry codes
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified